Shah Niel, Saleh Mohamed, Jyala Abhilasha, Hayagreev Vibha, Saad Muhammad
Internal Medicine, Einstein Medical Center Philadelphia, Philadelphia, USA.
Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, USA.
Cureus. 2022 Jul 22;14(7):e27158. doi: 10.7759/cureus.27158. eCollection 2022 Jul.
Coronavirus disease 2019 (COVID-19) can manifest differently in different patients, ranging from asymptomatic carriers to acute respiratory distress syndrome (ARDS). Cardiac involvement may occur with COVID-19 even without respiratory tract signs and symptoms of infection. Cardiac manifestations like heart failure (HF), myopericarditis, and cardiac arrhythmias are commonly reported. Cardiac injury with troponin leak is associated with increased mortality in COVID-19, and its clinical and radiographic features are difficult to distinguish from those of HF. COVID-19 is also known to cause pericardial inflammation, likely via direct cytotoxic effects or immune-mediated mechanisms. However, the definite mechanism is still unclear. We present here a case of myopericarditis complicated by pericardial effusion and cardiac tamponade in a COVID-19 infected patient with minimal pulmonary involvement.
2019冠状病毒病(COVID-19)在不同患者中可能有不同表现,从无症状携带者到急性呼吸窘迫综合征(ARDS)。即使没有呼吸道感染的体征和症状,COVID-19也可能累及心脏。心力衰竭(HF)、心肌心包炎和心律失常等心脏表现较为常见。肌钙蛋白泄漏导致的心脏损伤与COVID-19患者死亡率增加相关,其临床和影像学特征难以与HF区分。已知COVID-19也可引起心包炎症,可能通过直接细胞毒性作用或免疫介导机制。然而,确切机制仍不清楚。我们在此报告一例COVID-19感染患者,其患有心肌心包炎并伴有心包积液和心脏压塞,肺部受累较轻。